Meier CR, et al. - In this case-control study based on data from the UK-based Clinical Practice Research Datalink (CPRD), researchers analyzed the risk of cataract in relation to exposure to ACE inhibitors (ACEIs) and other antihypertensive drugs between 1995 and 2015. They evaluated a number of prescriptions for ACEI and other antihypertensive drugs in detail and explored the use of single ACEI substances. A total of 206,931 cataract cases and the same number of matched controls were recognized. They concluded that the use of ACEI was not correlated with a materially modified risk of cataract as compared to non-use of ACEI.